e-learning
resources
Virtual 2020
Pre-Congress Content
Non-invasive ventilation and nasal high flow: technical aspects and predictive scores
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In-vitro evaluation of pressurized metered dose inhalers in high flow oxygen system
y. M.Madney (Benisuef, Egypt), H. S. Harb (Benisuef, Egypt), B. Gil Gonçalves (Coimbra, Portugal), A. M. Esquinas (Murcia, Spain)
Source:
Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores
Session:
Non-invasive ventilation and nasal high flow: technical aspects and predictive scores
Session type:
E-poster session
Number:
1964
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
y. M.Madney (Benisuef, Egypt), H. S. Harb (Benisuef, Egypt), B. Gil Gonçalves (Coimbra, Portugal), A. M. Esquinas (Murcia, Spain). In-vitro evaluation of pressurized metered dose inhalers in high flow oxygen system. 1964
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Mobile video directly observed therapy can be used to improve at-home inhaler technique in children with asthma
New inhaler devices: the good, the bad, and the ugly
Clinically appropriate testing of different valved holding chamber (VHC)-facemask combinations investigating simulated delivered mass to carina
Related content which might interest you:
Pressurised metered dose inhalers (pMDIs) with integrated flow rate guidance.
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017
In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer.
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019
Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019
Albuterol delivery by soft mist and pressurized metered dose inhalers during noninvasive ventilation in a model of a spontaneously breathing child
Source: International Congress 2018 – Neonatology and paediatric intensive care
Year: 2018
Technique training doesn‘t improve patients ability to use pressurised metered dose inhalers (pMDIs)
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009
Objective measurement of inhalation profiles in patients using metered dose inhalers (MDIs)
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011
In vitro performance of a small non-electrostatic valved holding chamber made from metal with three different brands of pressurized metered dose inhalers
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006
Comparison of proficiency of pressurized metered dose inhaler (pMDI) use with asthma control
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Effect of the actuator orifice diameter on the biodisposition of a new budesonide CFC-free metered dose inhaler formulation
Source: Eur Respir J 2001; 18: Suppl. 33, 102s
Year: 2001
Comparison of systemic pharmacodynamic effects of two HFA formulations of formoterol fumarate delivered by pressurised metered dose inhaler in healthy subjects
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009
In vitro comparison of aerosol characteristics of HFA albuterol (salbutamol) pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs)
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011
In vitro comparison of aerosol characteristics of HFA ipratropium bromide pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs)
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011
Two-tone trainer maintains a slow inhalation rate when using a metered dose inhaler (MDI)
Source: Eur Respir J 2005; 26: Suppl. 49, 47s
Year: 2005
In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation.
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Improvement in the drug delivery of salmeterol/fluticasone via a novel breath actuatedpressurized metered dose inhaler with a dose counter
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019
Feedback during treatment results in increased adherence when using a pressurized metered dose inhaler with valved holding chamber in paediatric patients with asthma
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008
Assessment of the suitability of filters for use in clinical studies with an HFA fluticasone propionate pressurized metered dose inhaler (pMDI) and a valved holding chamber (VHC)
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011
In vitro performance characteristics of a novel multi-dose dry powder inhaler Airmax™ at different inspiratory flow rates
Source: Eur Respir J 2002; 20: Suppl. 38, 541s
Year: 2002
In vitro delivery of formoterol via a novel multi-dose dry powder inhaler, at clinically relevant inspiratory flow rates
Source: Eur Respir J 2003; 22: Suppl. 45, 472s
Year: 2003
In vitro
comparison of output and particle size distribution of budesonide from metered-dose inhaler with three spacer devices during pediatric tidal breathing
Source: Eur Respir J 2005; 26: Suppl. 49, 161s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept